# Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

> **NCT07222813** · NA · NOT_YET_RECRUITING · sponsor: **Echosens** · enrollment: 149 (estimated)

## Conditions studied

- Heart Failure
- Heart Failure - NYHA II - IV

## Interventions

- **DEVICE:** FibroScan
- **PROCEDURE:** Right-sided Heart Catheterization
- **PROCEDURE:** Transthoracic echocardiography
- **BIOLOGICAL:** Blood Sample Analysis

## Key facts

- **NCT ID:** NCT07222813
- **Lead sponsor:** Echosens
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-15
- **Target enrollment:** 149 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222813, "Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07222813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*